January 23, 2025

Jinbei oral liquid for idiopathic pulmonary fibrosis: a randomized placebo-controlled trial – Nature

January 21, 2025

Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis – BMC Medicine

January 10, 2025

Mediar Therapeutics Enters into Global Licensing Agreement with Lilly to Advance First-in-Class WISP1 Antibody for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) – PR Newswire

January 9, 2025

Comparing multi-texture fibrosis analysis versus binary opacity-based abnormality detection for quantitative assessment of idiopathic pulmonary fibrosis – Nature

January 7, 2025

Comprehensive analyses of immune activity in COVID-19-vaccinated idiopathic pulmonary fibrosis patients – Frontiers